Literature DB >> 23174686

Fat-free mass depletion and inflammation in patients with bronchiectasis.

Gabriel Olveira1, Casilda Olveira, Inmaculada Gaspar, Nuria Porras, Gracia Martín-Núñez, Elehazara Rubio, Natalia Colomo, Gemma Rojo-Martínez, Federico Soriguer.   

Abstract

Fat-free mass depletion has been related to increased inflammatory activity and to increased morbidity and mortality in chronic respiratory diseases. The aims of our study were to determine the nutritional status and serum levels of adipocytokines and inflammatory cytokines in patients with bronchiectasis of any etiology and their relation with respiratory parameters. A cross-sectional study was designed that included patients aged >14 years with diagnostic criteria for bronchiectasis. Anthropometric parameters; a diet questionnaire; hand grip dynamometry; levels of leptin, adiponectin, interleukin-6 (IL-6), tumor necrosis factor-α, and ultrasensitive C-reactive protein; as well as respiratory parameters (ie, clinical, radiologic, and spirometric values) were assessed. Ninety-three clinically stable patients were recruited, 43 with cystic fibrosis, 31 with noncystic fibrosis bronchiectasis, and 19 with cystic fibrosis transmembrane conductance regulator-related bronchiectasis. Fat-free mass depletion was present in 31% of patients, with no differences according to the etiology of the bronchiectasis. Correlations were found between inflammatory cytokines (ie, IL-6) and exacerbations, bronchorrea, forced expiratory volume in 1 second, and Bhalla score. Patients with worse respiratory disease severity, malnutrition, and diabetes had significantly higher levels of IL-6. Adiponectin correlated significantly and positively with fat mass and fat mass index and negatively with fat-free mass, fat-free mass index, and hand dynamometry. Leptin correlated positively with body mass index, fat mass and fat mass index, and negatively with fat-free mass, fat-free mass index, and dynamometry. Patients with bronchiectasis present a high percentage of fat-free mass depletion, independent of the etiology of the disease. The levels of inflammatory cytokines (especially IL-6) may be useful markers of disease severity. Adiponectin levels were higher in patients with fat-free mass depletion.
Copyright © 2012 Academy of Nutrition and Dietetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23174686     DOI: 10.1016/j.jand.2012.08.013

Source DB:  PubMed          Journal:  J Acad Nutr Diet        ISSN: 2212-2672            Impact factor:   4.910


  13 in total

1.  Inflammation and Oxidation Biomarkers in Patients with Cystic Fibrosis: The Influence of Azithromycin.

Authors:  Casilda Olveira; Alicia Padilla; Antonio Dorado; Victoria Contreras; Eduardo Garcia-Fuentes; Elehazara Rubio-Martin; Nuria Porras; Esperanza Doña; Ana Carmona; Gabriel Olveira
Journal:  Eurasian J Med       Date:  2017-06

Review 2.  Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations.

Authors:  Joaquim Gea; Antoni Sancho-Muñoz; Roberto Chalela
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

3.  Validation of a Quality of Life Questionnaire for Bronchiectasis: psychometric analyses of the Spanish QOL-B-V3.0.

Authors:  Casilda Olveira; Gabriel Olveira; Francisco Espildora; Rosa-Maria Giron; Gerard Muñoz; Alexandra L Quittner; Miguel-Angel Martinez-Garcia
Journal:  Qual Life Res       Date:  2013-10-19       Impact factor: 4.147

4.  Relation between inflammatory cytokine levels in serum and bronchoalveolar lavage fluid and gene polymorphism in young adult patients with bronchiectasis.

Authors:  Gulhan Ayhan; Dilaver Tas; Ismail Yilmaz; Oguzhan Okutan; Ersin Demirer; Omer Ayten; Zafer Kartaloglu
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

5.  Serum albumin is a predictor of respiratory hospitalization in patients with bronchiectasis.

Authors:  Sunmi Ju; Jong Hwan Jeong; Manbong Heo; I Re Heo; Tae Hoon Kim; Ho Cheol Kim; Jung-Wan Yoo; Yu Ji Cho; Yi Yeong Jeong; Jong Deog Lee; Seung Jun Lee
Journal:  Chron Respir Dis       Date:  2021 Jan-Dec       Impact factor: 2.444

6.  Academy of Nutrition and Dietetics: 2020 Cystic Fibrosis Evidence Analysis Center Evidence-Based Nutrition Practice Guideline.

Authors:  Catherine M McDonald; Jessica A Alvarez; Julianna Bailey; Ellen K Bowser; Kristen Farnham; Mark Mangus; Laura Padula; Kathleen Porco; Mary Rozga
Journal:  J Acad Nutr Diet       Date:  2020-06-19       Impact factor: 5.234

7.  Association of body mass index with disease severity and prognosis in patients with non-cystic fibrosis bronchiectasis.

Authors:  Q Qi; T Li; J C Li; Y Li
Journal:  Braz J Med Biol Res       Date:  2015-07-10       Impact factor: 2.590

8.  Prognostic Value of Concomitant Bronchiectasis in Newly Diagnosed Diffuse Panbronchiolitis Patients on a Maintenance Therapy with Macrolides.

Authors:  Benyong Xu; Yanhua Mao; Xiaoyu Wan; Jianhui Chen; Meiping Ye; Mengling Zhan; Liyun Xu; Lan Zhao; Bing Li; Zhemin Zhang; Yang Liu; Haiqing Chu
Journal:  Can Respir J       Date:  2019-03-10       Impact factor: 2.409

9.  Osteopenia and Osteoporosis in Patients with Bronchiectasis: Association with Respiratory Parameters, Body Composition, Muscle Strength and Bone Remodeling Biomarkers.

Authors:  V Contreras-Bolívar; G Olveira; N Porras; E Acosta; E Rubio-Martín; M J Tapia-Guerrero; J Abuin-Fernández; C Olveira
Journal:  Sci Rep       Date:  2019-10-10       Impact factor: 4.379

Review 10.  The Efficacy of Therapeutic Respiratory Muscle Training Interventions in People with Bronchiectasis: A Systematic Review and Meta-Analysis.

Authors:  Rocio Martín-Valero; Ana Maria Jimenez-Cebrian; Jose A Moral-Munoz; Maria de-la-Casa-Almeida; Manuel Rodriguez-Huguet; Maria Jesus Casuso-Holgado
Journal:  J Clin Med       Date:  2020-01-15       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.